Table 1.
Physician Respondents (n=76) (%) | Pharmacist† Respondents (n=59) (%) | |
---|---|---|
Number of years in practice | ||
Less than 5 years | 11 (14) | 20 (34) |
5–10 years | 16 (21) | 20 (34) |
More than 10 years | 49 (64) | 19 (32) |
Survey response rate | 27% | 50% |
Medical specialty (response rate) | ||
Cardiology | 9 (20) | 9 |
Infectious diseases | 5 (ND‡) | 12 |
Neurology | 4 (ND‡) | 7 |
Oncology | 9 (47) | 7 |
Pain | 11 (48) | 9 |
Primary care | 16 (27) | 18 |
Psychiatry | 14 (ND‡) | 5 |
Transplant | 11 (35) | 17 |
Currently using PG testing in practice | 22 (29) | 19 (32) |
Interest in starting PG testing in practice | 48 (63) | 32 (54) |
Currently not using PG and not interested in integrating PG | 6 (8) | 8 (14) |
Clinicians indicating interest in discussing their interest in clinical PG with us | 49 (64) | 33 (56) |
Observational studies sufficient evidence for PG testing | 45 (59) | 35 (59) |
ND = not determined; PG = pharmacogenetics.
Response rate for pharmacists across medical specialties is not determined given that all pharmacists selected more than one clinical specialty in the survey.
Unable to calculate response rate because we did not know the number of physicians who received the survey.